PATENT CLAIM ANALYSIS

Application Number: 16100048
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2020-02
Patent Classification: ["null", "null"]

Abstract:
The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a colon release coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Claim (Index 8):
The oral dosage form of  claim 7 , wherein the extruded and spheronized pellets comprise at least 90% w/w cholestyramine.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 96.0
- Lexical Diversity: 1.44118
- Patent Class: nan
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15988281', '15449781', '15988560', '15449645', '11804259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.588292159128201
- 35 USC 102 Novelty (BERT): 0.6241905499739067
- Combined Prediction Score: 0.5918819982127715
- Mean Citation Score: 416.622486
- Max Citation Score: 580.3915
- Similarity Product: 566.1130220167638

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test